Curriculum · Infection Control
Outpatient antibiotic stewardship
What it is
Outpatient antibiotic stewardship is the work a primary care practice does so that antibiotics are used only for appropriate indications. Its core elements are commitment, action for policy and practice, tracking and reporting, and education and expertise. In a primary care community health center the medical director may identify antibiotic stewardship as a priority and communicate with all clinical and administrative staff members to express a consistent message to patients about appropriate indications for antibiotic use.
How it is diagnosed
A procalcitonin-guided therapy algorithm helps decide whether an acute respiratory infection in an adult is bacterial. Using such an algorithm reduces antibiotic use by 3.47 days without increasing either morbidity or mortality. The levels are read as follows.
- Below 0.10 mg/dL a bacterial infection is highly unlikely and it is strongly recommended that antibiotics not be prescribed.
- From 0.10 to 0.24 mg/dL a bacterial infection is still unlikely and it is recommended that antibiotics not be used.
- From 0.25 to 0.50 mg/dL a bacterial infection is likely and antibiotics are recommended.
- Above 0.50 mg/dL a bacterial infection is very likely and it is strongly recommended that antibiotics be given.
How it is treated
Writing a delayed antibiotic prescription when appropriate is an example of an action aimed at improving antibiotic prescribing practices. Delayed prescription strategies are effective in reducing antibiotic use for appropriate conditions such as upper respiratory infections and otitis media. Using evidence-based guidelines, clinical decision support tools and triage systems also results in decreased antibiotic use. Call centers or nurse triage reduce unnecessary visits, and nurses can effectively manage upper respiratory infection symptoms by phone.
Duration matters as much as the decision to prescribe. A 5-day course of antibiotics for community-acquired pneumonia produces the same clinical success rates as longer treatment programs, with no difference in the rate of clinical improvement, hospital readmissions or mortality.